ESC 22: Hot Line & Late-breaking Science Video Collection
Published: 24 August 2022
-
Views:
6266 -
Likes:
7
-
Views:
6266 -
Likes:
7
-
Up Next
-
2m 55sPart 4 | Session 14 The EMMY Trial: Empagliflozin in Patients with Acute MI
-
4m 51sPart 4 | Session 15 COVID-PACT: Antithrombotic Therapy in Critically Ill COVID-19 Pts
-
4m 59sPart 4 | Session 16 ACT: Anti-Coronavirus Therapies to Prevent Progression of COVID-19
-
5m 51sPart 4 | Session 17 PERSPECTIVE: Sacubitril/Valsartan & Cognitive Function in HFmrEF & HFpEF
-
1m 29sPart 5 | Session 1 Behind the Heart: Michelle Goonasekera
-
1m 15sPart 5 | Session 2 Behind the Heart: Isla S Mackenzie
-
6m 28sPart 5 | Session 3 Behind the Heart: Douglas Bradley
-
2m 20sPart 5 | Session 4 Behind the Heart: Ashkan Shoamanesh
-
1m 22sPart 5 | Session 5 Behind the Heart: Mukul Sharma
-
1m 18sPart 5 | Session 6 Behind the Heart: Geoffrey Strange
-
4m 30sPart 5 | Session 7 Behind the Heart: Martha Gulati
-
1m 50sPart 5 | Session 8 Behind the Heart: John H Alexander
-
1m 54sPart 5 | Session 9 Behind the Heart: Renato D Lopes
-
1m 16sPart 5 | Session 10 Behind the Heart: David Newby
-
1m 43sPart 5 | Session 11 Behind the Heart: Faiez Zannad
-
1m 8sPart 5 | Session 12 Behind the Heart: Harald Sourij
-
2m 2sPart 5 | Session 13 Behind the Heart: David Berg
-
1m 11sPart 5 | Session 14 Behind the Heart: Sanjit Jolly
-
1m 20sPart 5 | Session 15 Behind the Heart: Mirvat Alasnag
-
4m 30sPart 5 | Session 16 Behind the Heart: Martha Gulati
-
2m 33sPart 5 | Session 17 Behind the Heart: Purvi Parwani
-
2m 51sPart 5 | Session 18 Behind the Heart: John McMurray
-
59sPart 5 | Session 19 Behind the Heart: Marco Valgimigli
-
6m 50sPart 6 | Session 1 REVIVED-BCIS2, RTC, FRAME-AMI by Dr Mirvat Alasnag
-
9m 51sPart 6 | Session 2 DANCAVAS, DELIVER, SECURE by Dr Purvi Parwani
-
3m 29sPart 6 | Session 3 eBRAVE-AF, CAPLA, INVICTUS by Dr Afzal Sohaib
-
7m 2sPart 6 | Session 4 TIME, SECURE, DANCAVAS by Dr Martha Gulati
-
33m 19sPart 1 | Session 1 View from the Thoraxcenter – ESC 2022 Wrap Up Nicolas M Van Mieghem, Joost Daemen
-
24m 27sPart 1 | Session 2 View from the Thoraxcenter – ESC 2022 Preview Nicolas M Van Mieghem, Joost Daemen
-
17m 13sPart 2 | Session 1 Late-breaker Discussion: The INVICTUS Trial Harriette Van Spall, Ganesan Karthikeyan
-
11m 27sPart 2 | Session 2 Late-breaker Discussion: The DELIVER Trial Harriette Van Spall, Scott Solomon
-
14m 31sPart 2 | Session 3 Late-breaker Discussion: The REVIVED Trial Harriette Van Spall, Divaka Perera
-
11m 5sPart 2 | Session 4 Late-breaker Discussion: The ADVOR Trial Wilfried Mullens, Harriette Van Spall
-
24m 19sPart 3 ESC 22 Guidelines on Cardio-Oncology: Summary & Question Time Teresa López Fernández, Alexander Lyon, Arjun K Ghosh
-
5m 34sPart 4 | Session 1 ASCEND: Aspirin and Omega-3 Fatty Acids in Preventing Heart Failure Michelle Goonasekera
-
2m 29sPart 4 | Session 2 ALL-HEART: Allopurionol in the Treatment of Ischaemic Heart Disease Isla S Mackenzie
-
7m 9sPart 4 | Session 3 PACIFIC-STROKE: Dosing of Asundexian in Pts With Non-Cardioembolic Ischemic Stroke Ashkan Shoamanesh
-
4m 22sPart 4 | Session 4 PACIFIC-AMI: Asundexian on Top of DAPT After Acute Myocardial Infarction John H Alexander
-
6m 26sPart 4 | Session 6 AXIOMATIC-SSP: Milvexian in Additon to Aspirin and Clopidogrel for Secondary Stroke Prevention Mukul Sharma
-
3m 45sPart 4 | Session 7 Artificial Intelligence Detection of Severe Aortic Stenosis Geoffrey Strange
-
7m 25sPart 4 | Session 8 MOMENTUM 3: 5-year Results From HeartMate 3 LVAD Therapy Mandeep Mehra
-
4m 13sPart 4 | Session 9 MASTER DAPT Results at 15M with Prof Valgimigli Marco Valgimigli
-
3m 57sPart 4 | Session 10 APOLLO: Apixaban for Prevention of Thromboembolic Outcomes in COVID Renato D Lopes
-
3m 22sPart 4 | Session 11 The PRE18FFIR Trial: 18F-NaF PET for Vulnerable Coronary Plaque imaging After MI David Newby
-
5m 44sPart 4 | Session 12 FIDELITY: Finerenone in Pts With Chronic Kidney Disease Gerasimos Filippatos
Overview
What's hot at European Society of Cardiology (ESC) Congress 22?
Stay tuned and browse our curated coverage of the latest data in cardiology.
- For a concise line up of the most awaited trials join Prof Nicolas Van Mieghem and Dr Joost Daemen and their regular View From the Thoraxcenter series.
- For a deeper dive into key clinical trial data and applicability, host, Dr Harriette Van Spall talks with principal investigators in her Late-Breaker Discussion Series.
- Short, accessible Expert Interviews conducted with select faculty focusing on data, patient care and the future of their field.
- To mark the release of the new ESC Guidelines on Cardio-Oncology, we will feature a 10-minute summary and a 10-minute live audience Q&A.
- We asked some of the most prominent researchers today about their pathways in the Behind the Heart series.
Watch our Radcliffe Premiere TV to be transported to Barcelona.
More from this programme
Part 1
View From the Thoraxcenter: Review Series
Part 2
Late-breaker Discussion Series With Dr Harriette Van Spall
Part 3
ESC Guidelines on Cardio-Oncology: Summary & Question Time
Part 4
Hot Line & Late-breaking Interviews
Part 5
Behind the Heart from Barcelona
Part 6
3 Trials That Will Change Your Practice: Reviews
Faculty Biographies
Faiez Zannad
Professor of Therapeutics and Cardiology, Head of CIC
Prof Faiez Zannad is Professor of Therapeutics & Cardiology and Head of the Division of Heart Failure, Hypertension and Preventive Cardiology for the department of Cardiovascular Disease of the Academic Hospital (CHU) in Nancy and the Director of the Clinical Investigation Centre (Inserm-CHU).
Prof Zannad is currently the Chairman of the ESC Working group on Pharmacology and Drug Therapy as well as a Boardmember of the ESC Heart Failure Association. He is Past-President of the French Society of Hypertension.
Prof Zannad is Co-Editor-in-Chief for Fundamental and Clinical Pharmacology, the official journal of the European Pharmacology Societies Federation (EUPHAR). He chairs and organises annual international meetings on CardioVascular Clinical Trials (CVCT) and on Biomarkers in Heart Failure.